Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 24, 2026
03:30 PM - 04:30 PM ET
Targeting PTEN: Why It Matters
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Molecular Profiling in mHSPC: Informing Treatment Selection
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
All Hands on Deck: Multidisciplinary Coordination for Smarter Perioperative Care
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Managing Brain Metastases Through Multidisciplinary Team Collaboration
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Nadia Harbeck, MD, PhD
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.